FluroTech Ltd.

Recent News

  • FluroTech Submits Letter of Intention to the Drugs and Driving Committee

    Calgary, Alberta--(Newsfile Corp. - November 21, 2018) -  FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), is pleased to announce it has submitted its letter of intention to submit saliva-based roadside drug screening equipment for approval evaluation in early 2019 to the Drugs and Driving Committee (“DDC”), a committee within the Canadian Society of Forensic Science. The role of the DDC is to act as an advisory body to the Department of Justice with respect to issues of drug impaired driving. The DDC makes...

    2018-11-21 10:00 AM ET
  • FluroTech Protects Its Technological Advantage with Patent Application

    Calgary, Alberta--(Newsfile Corp. - November 5, 2018) -  FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), is pleased to announce two recently-filed patent applications to which the Company holds exclusive, irrevocable rights for use in the cannabis industry. The patents include an international patent application filed October 31, 2018 pursuant to the Patent Cooperation Treaty ("PCT"), and a national phase entry filing of the PCT application at the United States Patent and Trademark Office (the "USPTO") on November 2,...

    2018-11-05 10:00 AM ET
  • FluroTech Appoints a New Chief Financial Officer and a Vice President of Business Development

    Calgary, Alberta--(Newsfile Corp. - November 1, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company") is pleased to introduce Mr. Curtis Smith as Chief Financial Officer taking over responsibilities from Mr. Gary Jones, who has been appointed Vice President of Business Development. Over the past three years Mr. Smith led the finance team at Eguana Technologies Inc, a TSX-V and OTCQB traded company, where he restructured the finance group to prepare the company for its transition to a globally-recognized...

    2018-11-01 9:00 AM ET
  • FluroTech Designs a Cocaine Test for Roadside Impairment Testing

    Calgary, Alberta--(Newsfile Corp. - October 23, 2018) -  FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), a developer of a human saliva-based testing device designed to accurately measure

    2018-10-23 9:00 AM ET
  • FluroTech Applauds Canadian Cannabis Legalization and Provides Operational Update

    Calgary, Alberta--(Newsfile Corp. - October 19, 2018) -  FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), developer of the CompleTest™ device for cannabis quality control, detection of the Company's biomarker and developer of a human saliva testing device that determines concentrations of ∆9-tetrahydrocannabinol ("THC"), methamphetamines and cocaine for use in roadside and work place impairment testing, applauds the efforts by the Government of Canada and others to increase public awareness of the dangers of driving while impaired by drugs...

    2018-10-19 9:00 AM ET
  • FluroTech Receives Good Manufacturing Practice Validation of the CompleTest(TM) Cannabinoid Assays for THCa and CBDa

    Calgary, Alberta--(Newsfile Corp. - September 25, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), is pleased to report that preliminary Good Manufacturing Practice ("GMP") validation testing, done by the Drug Development and Innovation Center at the University of Alberta, of the CompleTest™ cannabinoid assays for THCa and CBDa were recorded at less than 2% difference when compared to the industry quality control standard High Performance Liquid Chromatography ("HPLC") technology.HPLC analytic equipment is considered highly technical to operate and reasonably...

    2018-09-25 9:00 AM ET
  • FluroTech Appoints Aurora's Former Chief Scientist Dr. MacMillan as Director of Scientific Research and Business Development

    Calgary, Alberta--(Newsfile Corp. - September 18, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), is pleased to announce the appointment of Dr. Trevor MacMillan as Director of Scientific Research and Business Development. With prior industry experience at Aurora Cannabis Inc., Dr. MacMillan brings with him an impressive background in plant breeding, biotechnology regulatory environments and quality control. He will be an integral part of FluroTech's scientific and business development teams."Dr. MacMillan brings a unique perspective of the Licensed...

    2018-09-18 9:00 AM ET
  • FluroTech Refiles Interim Filings

    Calgary, Alberta--(Newsfile Corp. - September 14, 2018) - FluroTech Ltd. (TSXV: TEST) ("FluroTech" or the "Company") announces that, further to its prior press release on September 10, 2018, the Company has refiled its June 30, 2018 interim financial statements and amended Management's Discussion & Analysis for the same period. The material changes to the interim filings were as a result of a change in the comparative periods presented in the interim filings, to properly reflect the change in financial year...

    2018-09-14 9:30 PM ET